Drug allergy screening: Difference between revisions
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
==Screening for Drug Allergy in Specific Circumstances== | ==Screening for Drug Allergy in Specific Circumstances== | ||
Neither allergy blood testing nor skin testing should be used for primary [[screening]] measures in healthy patients: they may be most useful as confirmatory tests when the patient’s history is compatible with an IgE-mediated reaction, and the patient is in need of a certain medication that may induce a severe reaction. | Neither allergy blood testing nor skin testing should be used for primary [[screening]] measures in healthy patients: they may be most useful as confirmatory tests when the patient’s history is compatible with an IgE-mediated reaction, and the patient is in need of a certain medication that may induce a severe reaction. | ||
* Skin prick testing (SPT) and intradermal testing (a test where a small amount of [[allergen]] is injected into the dermal layer of the skin) are useful for predicting an [[allergic reaction]] mediated by IgE-mediated reactions ([[type I hypersensitivity]]). Skin testing protocols are standardized for drugs such as [[penicillin]], and are also useful (but rarely positive) for [[local anesthetics]],[[muscle relaxants]], and very sensitive for high-molecular-weight protein substances such as [[insulin]] and [[monoclonal antibodies]]. Positive skin tests to these drugs confirm the presence of antigen-specific [[IgE]], and supports the diagnosis of a [[type I hypersensitivity]] reaction. The negative predictive value of penicillin skin testing is high, and therefore, a negative test is useful for ruling out a penicillin allergy. | * '''Skin prick testing''' (SPT) and '''intradermal testing''' (a test where a small amount of [[allergen]] is injected into the dermal layer of the skin) are useful for predicting an [[allergic reaction]] mediated by IgE-mediated reactions ([[type I hypersensitivity]]). Skin testing protocols are standardized for drugs such as [[penicillin]], and are also useful (but rarely positive) for [[local anesthetics]],[[muscle relaxants]], and very sensitive for high-molecular-weight protein substances such as [[insulin]] and [[monoclonal antibodies]]. Positive skin tests to these drugs confirm the presence of antigen-specific [[IgE]], and supports the diagnosis of a [[type I hypersensitivity]] reaction. The negative predictive value of penicillin skin testing is high, and therefore, a negative test is useful for ruling out a penicillin allergy. | ||
*Blood tests that measure levels of [[IgE]] against specific drug allergens, can confirm an allergic disorder. They are useful when skin testing cannot or should not be performed. The likelihood of an IgE-mediated clinical reaction often increases with the level of specific IgE, but these levels do not predict severity or guarantee a reaction will occur. In the appropriate setting, these tests can help in identifying specific allergens and assessing allergic disease | *'''Blood tests''' that measure levels of [[IgE]] against specific drug allergens, can confirm an allergic disorder. They are useful when skin testing cannot or should not be performed. The likelihood of an IgE-mediated clinical reaction often increases with the level of specific IgE, but these levels do not predict severity or guarantee a reaction will occur. In the appropriate setting, these tests can help in identifying specific allergens and assessing allergic disease | ||
Revision as of 13:49, 20 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]
|
Drug Allergy |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Drug allergy screening On the Web |
|
American Roentgen Ray Society Images of Drug allergy screening |
|
Risk calculators and risk factors for Drug allergy screening |
Overview
Screening options for drug allergies are limited. This is mainly because drug allergies fall under the type B unpredictable type drug reactions that occur only in susceptible individuals. To screen for drug allergy, one would have to be exposed to the drug, which may mean putting the individual at an uneccesary risk for a severe drug reaction through a screening test.
Screening for Drug Allergy in Specific Circumstances
Neither allergy blood testing nor skin testing should be used for primary screening measures in healthy patients: they may be most useful as confirmatory tests when the patient’s history is compatible with an IgE-mediated reaction, and the patient is in need of a certain medication that may induce a severe reaction.
- Skin prick testing (SPT) and intradermal testing (a test where a small amount of allergen is injected into the dermal layer of the skin) are useful for predicting an allergic reaction mediated by IgE-mediated reactions (type I hypersensitivity). Skin testing protocols are standardized for drugs such as penicillin, and are also useful (but rarely positive) for local anesthetics,muscle relaxants, and very sensitive for high-molecular-weight protein substances such as insulin and monoclonal antibodies. Positive skin tests to these drugs confirm the presence of antigen-specific IgE, and supports the diagnosis of a type I hypersensitivity reaction. The negative predictive value of penicillin skin testing is high, and therefore, a negative test is useful for ruling out a penicillin allergy.
- Blood tests that measure levels of IgE against specific drug allergens, can confirm an allergic disorder. They are useful when skin testing cannot or should not be performed. The likelihood of an IgE-mediated clinical reaction often increases with the level of specific IgE, but these levels do not predict severity or guarantee a reaction will occur. In the appropriate setting, these tests can help in identifying specific allergens and assessing allergic disease